CD19 and neoplasm: In their study, the oncolytic vaccinia virus coded for the truncated nonsignaling variant of CD19 (OV19t) worked as a vehicle to selectively infect tumor cells and express CD19 on the surface of tumor cells, and then these infected tumor cells could be targeted by CAR-T cells [82].